Prosperity Consulting Group, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1910398 OWINGS MILLS, MD

Position in REGN

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$278,150

+$15,715 QoQ

Shares Held

360

+5.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Prosperity Consulting Group, LLC holds $912,351 across 5 Biotechnology names. REGN ranks #2 (30.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,041	$344,435
2	REGN	Regeneron Pharmaceuticals, Inc. This page	360	$278,150
3	VRTX	Vertex Pharmaceuticals Inc / Ma	558	$249,169
4	BDTX	Black Diamond Therapeutics, Inc.	11,355	$24,186
5	ENLV	Enlivex Ltd.	17,647	$16,411

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$278,150	360	+5.9%	Shares	Sole	2026-05-05
2025-12-31	$262,435	340	+53.2%	Shares	Sole	2026-02-17
2024-09-30	$233,375	222	—	Shares	Sole	2024-10-15
No filing history on record for this holder in this stock.